Abid Hussain

In stealth mode

Celera Semiconductor is the next-generation analog semiconductor company that specializes in AI-accelerated silicon development. By leveraging fully automated, AI-powered development flows crafted by highly experienced analog IC experts, Celera delivers custom analog ICs and mixed-signal solutions 10X faster than legacy IC vendors, catering to every application, big or small, including PMICs.

Superior Sensor Technology is an innovative, high technology company committed to producing a new generation of integrated, high-performance, low-pressure sensors for industrial, medical and HVAC applications. Our proprietary pressure sensor technology with advanced programmable software features enable customers to develop higher performing, more reliable equipment with a reduced bill-of-materials (BOM) cost basis.

Gazelle is a fabless startup that was founded in 2013 in Silicon Valley, developing disruptive IC (integrated circuit) solutions for the power management market. Contact us for more details: info@gazellesemi.com

RenovoRx is a clinical-stage biopharmaceutical company focused on fighting cancer through the localized treatment of difficult to treat tumors via our proprietary RenovoRx Trans-Arterial Micro-Perfusion (RenovoTAMP®) therapy platform. RenovoTAMP utilizes approved chemotherapeutics with validated mechanisms of action and well-established safety and side effect profiles, with the goal of increasing their efficacy, improving their safety, and widening their therapeutic window. Our lead product candidate, RenovoGem, is a combination of gemcitabine and our patented delivery system regulated by the FDA as a novel oncology drug product to treat unresectable locally advanced pancreatic cancer (LAPC). Targeted therapy via RenovoTAMP platform safely and without transmission to non-targeted areas, is our primary focus. RenovoRx’s patent portfolio currently includes seven issued US patents and one European patent for ourtechnology with several additional patents pending in the US, Europe, and Asia. After demonstrating a median survival of 27.9 months in Phase 1/2 clinical trials vs. 12-15 months reported in historical studies for this patient population, RenovoRx secured two separate Orphan Drug Designations from the FDA for intra-arterial gemcitabine: pancreatic cancer and bile duct cancer (cholangiocarcinoma). This therapy is being further studied in the currently enrolling Phase 3 TIGeR-PaC clinical trial in pancreatic cancer and has a primary endpoint of overall survival and several secondary endpoints, including quality of life. The Phase 3 TIGeR-PaC clinical trial is enrolling unresectable locally advanced pancreatic cancer patients (LAPC) in the United States.

Founder-Focused Deeptech Ventures Accelerated by AI

In stealth mode

Celera Semiconductor is the next-generation analog semiconductor company that specializes in AI-accelerated silicon development. By leveraging fully automated, AI-powered development flows crafted by highly experienced analog IC experts, Celera delivers custom analog ICs and mixed-signal solutions 10X faster than legacy IC vendors, catering to every application, big or small, including PMICs.

Liberating the analog/mixed-signal IC industry by improving R&D efficiency 100X. Celera delivers the impossible​: fully automated analog/mixed-signal IC development lightning fast and the push of a button. This unburdens the industry to pursue an estimated $30B in new profitable growth ushering the next generation of semiconductor devices: Silicon 3.0 - Move Fast and Build Things.

Superior Sensor Technology is an innovative, high technology company committed to producing a new generation of integrated, high-performance, low-pressure sensors for industrial, medical and HVAC applications. Our proprietary pressure sensor technology with advanced programmable software features enable customers to develop higher performing, more reliable equipment with a reduced bill-of-materials (BOM) cost basis.